Clinical Trials Logo

Arthroplasty, Hip Replacement clinical trials

View clinical trials related to Arthroplasty, Hip Replacement.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03393819 Completed - Clinical trials for Arthroplasty, Hip Replacement

Efficacy of Surgical Skin Preparation Solutions in Hip Arthroplasty Surgery

Start date: October 29, 2014
Phase: N/A
Study type: Interventional

This study will assess the efficacy of two of the most commonly used surgical skin-preparation solutions: Chloraprep (chlorhexidine-alcohol) and Duraprep (iodine-alcohol) at eliminating bacteria from the hip site by evaluating the residual bacteria present following surgical skin-preparation.

NCT ID: NCT02839876 Completed - Osteoarthritis Clinical Trials

Intravenous Versus Oral Acetaminophen in Primary Total Hip Arthroplasty

Start date: March 14, 2017
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine if intravenous acetaminophen is superior to oral acetaminophen when used as part of a multimodal pathway for primary total hip arthroplasty.

NCT ID: NCT02580214 Completed - Perioperative Care Clinical Trials

Immunonutrition in Total Hip Arthroplasty

Immunehip
Start date: May 2013
Phase: Phase 2/Phase 3
Study type: Interventional

The aim of this pilot study was to investigate whether the use of a multimodal protocol of preoperative care plus preoperative immune nutrition would decrease the length of stay and acute phase inflammation in patients submitted to total hip arthroplasty (THA). The study was designed to be randomized and controlled, but not double blind. The patients were randomized to receive either preoperative care based on evidence plus immune nutrition for 5 days prior to surgery (Acerto group) or traditional preoperative care (control group). Main endpoints were length of stay and acute-phase postoperative response

NCT ID: NCT02342236 Completed - Clinical trials for Delirium, Dementia, Amnestic, Cognitive Disorders

Cerebral Regional Oxygen Saturation and Markers of Brain Damage During Primary Hip Arthroplasty

Start date: June 2014
Phase: N/A
Study type: Interventional

Postoperative Cognitive Disorders (POCD) are common in hospitalized people > 60 year old, especially in orthopedic patients. Etiology of POCD is complex, and in some aspects still remains unclear. The role of thromboembolic events in etiology of POCD was discussed. The incidence of such events in patients who underwent big joints arthroplasty can be as high as 40 to 60%, although some cases are subclinical. Thromboembolic material can block a blood flow through a vessels in the brain. As a consequence cerebral neurons can be damaged or destroyed. After neuronal damage specific substances, such as S100B protein, glial fibrillary acidic protein (GFAP) and neuron-specific enolase (NSE) are released to the blood. The serum concentrations of these biomarkers can be measured. Moreover, the block of blood flow will decrease regional cerebral saturation in affected parts of the brain. In this project the authors would like to analyze the correlation between the regional cerebral saturation and serum concentration of both S100B protein and GFAP in orthopedic patients scheduled to primary hip arthroplasty.

NCT ID: NCT02338661 Completed - Clinical trials for Arthroplasty, Hip Replacement

Clinical Observation Study With the SBG Stem

Start date: January 2004
Phase:
Study type: Observational

This study is a prospective, single-center, postmarket clinical observation to observe the clinical and radiographic long-term performance of the SBG hip stem.

NCT ID: NCT01514006 Completed - Anemia Clinical Trials

Postoperative Anemia and Functional Outcomes After Fast-track Primary Hip Arthroplasty

Start date: January 2012
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate the possible association between postoperative anaemia and functional outcomes the first 2 weeks after primary hip arthroplasty. The investigators hypothesise that patients with a higher degree of postoperative anaemia have impaired postoperative rehabilitation as measured by standardized functional outcome tests.